Jean Jacques Bienaime
Director · Ascendis Pharma A/S
Individual9 10b5-1 trades
- 2025
- Sep 28, 2026
- 21
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jean Jacques Bienaime files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Flemming Steen Jensen - $4.64M in ASND purchases and sales in the last 12 months
- Mads Bodenhoff - $811K in ASND purchases and sales in the last 12 months
- Esther Cho - $124K in KROS purchases and sales in the last 12 months
- Jasbir Seehra - $113K in KROS purchases and sales in the last 12 months
- Lorena Raquel Lerner - $100K in KROS purchases and sales in the last 12 months
- Scott Thomas Smith - $78K in ASND purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jean Jacques Bienaime?
Jean Jacques Bienaime is a corporate insider, tracked as Director of Ascendis Pharma A/S (ASND). InsiderAlpha holds 21 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jean Jacques Bienaime submitted recently?
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Jean Jacques Bienaime been buying or selling stock?
Recorded transactions: 20 open-market purchases ($1.17M) and 2 open-market sales ($204K) across all tracked filings.
